Here's Why This Biotherapeutics Company's Stock Surged Higher by 30% Today

Shares in Arcutis Biotherapeutics (NASDAQ: ARQT) soared by almost 30% in trading to 10:30 a.m. ET today. The move comes after ...
The American Journal of Managed Care

Non-Ssteroidal Topical Therapies for Pediatric Atopic Dermatitis: Reducing Corticosteroid Dependence and Biologic Escalation

Experts discuss the impact of severe eczema on children’s daily lives and the role of newer non-steroidal topical therapies ...
The Manila Times

Arcutis Outlines Strategy for Driving Sustainable Growth and Announces Third Quarter 2025 Financial Results

Q3 2025 net product revenue for ZORYVE® (roflumilast) was $99.2 million, a 122% increase compared to Q3 of 2024, and a 22% increase compared to Q2 of 2025 ZORYVE cream 0.05% received U.S. Food and ...

Hammerling-Hodgers: Skin conditions with Parkinson's disease are common and manageable

Skin conditions with Parkinson’s disease are common and manageable. By paying attention to these symptoms, patients can ...